Global recombinant trypsin solution market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing demand for recombinant trypsin solution in insulin manufacturing and vaccines manufacturing applications, as well as cell culture applications.
The global recombinant trypsin solution market has been segmented on the basis of type into solid and liquid; on the basis of application into insulin manufacturing, vaccines manufacturing, and cell culture; and on the basis of region into North America, Latin America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA). North America accounted for a major share in 2017 owing to its high adoption rate in insulin manufacturing application followed by Europe owing to its high adoption rate in vaccines manufacturing application. APAC is expected to witness significant growth during the forecast period due to increasing demand from emerging economies such as China and India coupled with growing awareness about recombinant trypsin solutions among end-users.
-The global recombinant trypsin solution market is expected to grow at a CAGR of 5.5% during the forecast period.
-The global recombinant trypsin solution market is expected to reach USD 1,890 million by 2023 from USD 1,400 million in 2017.
-Increasing prevalence of chronic diseases such as diabetes and cancer are driving the growth of the global recombinant trypsin solution market.
-Increasing demand for protein rich diet and increasing awareness about protein intake are also driving the growth of the global recombinant trypsin solution market.
Industry Growth Insights published a new data on “Recombinant Trypsin Solution Market”. The research report is titled “Recombinant Trypsin Solution Market research by Types (Solid, Liquid), By Applications (Insulin Manufacturing, Vaccines Manufacturing, Cell Culture, Other), By Players/Companies Novozymes, Thermo Fisher, Roche, BBI Group, Merck, Biological Industries, Yaxin Bio, Lonza, Yocon Hengye Bio, Biosera, BasalMedia, Solarbio”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Recombinant Trypsin Solution Market Research Report
By Type
Solid, Liquid
By Application
Insulin Manufacturing, Vaccines Manufacturing, Cell Culture, Other
By Companies
Novozymes, Thermo Fisher, Roche, BBI Group, Merck, Biological Industries, Yaxin Bio, Lonza, Yocon Hengye Bio, Biosera, BasalMedia, Solarbio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Recombinant Trypsin Solution Market Report Segments:
The global Recombinant Trypsin Solution market is segmented on the basis of:
Types
Solid, Liquid
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Insulin Manufacturing, Vaccines Manufacturing, Cell Culture, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novozymes
- Thermo Fisher
- Roche
- BBI Group
- Merck
- Biological Industries
- Yaxin Bio
- Lonza
- Yocon Hengye Bio
- Biosera
- BasalMedia
- Solarbio
Highlights of The Recombinant Trypsin Solution Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Solid
- Liquid
- By Application:
- Insulin Manufacturing
- Vaccines Manufacturing
- Cell Culture
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Recombinant Trypsin Solution Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Recombinant trypsin solution is a mixture of recombinant human and bovine trypsin. It is used to dissolve proteins in water or other solutions.
Some of the major companies in the recombinant trypsin solution market are Novozymes, Thermo Fisher, Roche, BBI Group, Merck, Biological Industries, Yaxin Bio, Lonza, Yocon Hengye Bio, Biosera, BasalMedia, Solarbio.
The recombinant trypsin solution market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Recombinant Trypsin Solution Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Recombinant Trypsin Solution Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Recombinant Trypsin Solution Market - Supply Chain
4.5. Global Recombinant Trypsin Solution Market Forecast
4.5.1. Recombinant Trypsin Solution Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Recombinant Trypsin Solution Market Size (000 Units) and Y-o-Y Growth
4.5.3. Recombinant Trypsin Solution Market Absolute $ Opportunity
5. Global Recombinant Trypsin Solution Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Recombinant Trypsin Solution Market Size and Volume Forecast by Type
5.3.1. Solid
5.3.2. Liquid
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Recombinant Trypsin Solution Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Recombinant Trypsin Solution Market Size and Volume Forecast by Application
6.3.1. Insulin Manufacturing
6.3.2. Vaccines Manufacturing
6.3.3. Cell Culture
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Recombinant Trypsin Solution Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Recombinant Trypsin Solution Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Recombinant Trypsin Solution Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Recombinant Trypsin Solution Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Recombinant Trypsin Solution Demand Share Forecast, 2019-2026
9. North America Recombinant Trypsin Solution Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Recombinant Trypsin Solution Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Recombinant Trypsin Solution Market Size and Volume Forecast by Application
9.4.1. Insulin Manufacturing
9.4.2. Vaccines Manufacturing
9.4.3. Cell Culture
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Recombinant Trypsin Solution Market Size and Volume Forecast by Type
9.7.1. Solid
9.7.2. Liquid
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Recombinant Trypsin Solution Demand Share Forecast, 2019-2026
10. Latin America Recombinant Trypsin Solution Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Recombinant Trypsin Solution Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Recombinant Trypsin Solution Market Size and Volume Forecast by Application
10.4.1. Insulin Manufacturing
10.4.2. Vaccines Manufacturing
10.4.3. Cell Culture
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Recombinant Trypsin Solution Market Size and Volume Forecast by Type
10.7.1. Solid
10.7.2. Liquid
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Recombinant Trypsin Solution Demand Share Forecast, 2019-2026
11. Europe Recombinant Trypsin Solution Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Recombinant Trypsin Solution Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Recombinant Trypsin Solution Market Size and Volume Forecast by Application
11.4.1. Insulin Manufacturing
11.4.2. Vaccines Manufacturing
11.4.3. Cell Culture
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Recombinant Trypsin Solution Market Size and Volume Forecast by Type
11.7.1. Solid
11.7.2. Liquid
118. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Recombinant Trypsin Solution Demand Share, 2019-2026
12. Asia Pacific Recombinant Trypsin Solution Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Recombinant Trypsin Solution Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Recombinant Trypsin Solution Market Size and Volume Forecast by Application
12.4.1. Insulin Manufacturing
12.4.2. Vaccines Manufacturing
12.4.3. Cell Culture
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Recombinant Trypsin Solution Market Size and Volume Forecast by Type
12.7.1. Solid
12.7.2. Liquid
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Recombinant Trypsin Solution Demand Share, 2019-2026
13. Middle East & Africa Recombinant Trypsin Solution Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Recombinant Trypsin Solution Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Recombinant Trypsin Solution Market Size and Volume Forecast by Application
13.4.1. Insulin Manufacturing
13.4.2. Vaccines Manufacturing
13.4.3. Cell Culture
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Recombinant Trypsin Solution Market Size and Volume Forecast by Type
13.7.1. Solid
13.7.2. Liquid
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Recombinant Trypsin Solution Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Recombinant Trypsin Solution Market: Market Share Analysis
14.2. Recombinant Trypsin Solution Distributors and Customers
14.3. Recombinant Trypsin Solution Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Novozymes
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Thermo Fisher
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. BBI Group
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Merck
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Biological Industries
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Yaxin Bio
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Lonza
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Yocon Hengye Bio
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Biosera
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. BasalMedia
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Solarbio
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
